Carl Zeiss Meditec AG
AFX: XETR (DEU)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
€21.00 | Vkdtjb | Dbqrlfkwg |
Carl Zeiss Starts 2024 on a Disappointing Note, With Weak Contributions From China and Americas
Business Strategy and Outlook
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: ophthalmic devices, or OPT, and microsurgery, or MCS.